Classic choroidal neovascularization developing after photodynamic therapy in eyes with polypoidal choroidal vasculopathy

Japanese Journal of Ophthalmology

Volumn 55, Issue 3, 2011, Pages 241-247

  Imasawa, Mitsuhiro ^a   Sakurada, Yoichi ^a   Iijima, Hiroyuki ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Classic choroidal neovascularization; Photodynamic therapy; Polypoidal choroidal vasculopathy; Risk factors

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PHOTODYNAMIC THERAPY; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; RETINA EDEMA; RETROSPECTIVE STUDY; SEX DIFFERENCE; SUBRETINAL NEOVASCULARIZATION;

AGED; AGED, 80 AND OVER; CHOROID; CHOROID DISEASES; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PHOTOCHEMOTHERAPY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 79960066865     PISSN: 00215155     EISSN: 16132246     Source Type: Journal    
DOI: 10.1007/s10384-011-0006-6     Document Type: Article

References (24)

1. WM Chan DS Lam TY Lai DT Liu KK Li Y Yao, et al. 2004 Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series Ophthalmology 111 1576 1584 15288991 10.1016/j.ophtha.2003.12.056 (Pubitemid 39030815)
2. T Ogino M Takeda H Imaizumi U Okushiba 2007 Photodynamic therapy for age-related macular degeneration in Japanese patients: results after one year Jpn J Ophthalmol 51 210 215 17554484 10.1007/s10384-007-0436-3 (Pubitemid 46889507)
3. F Gomi M Ohji K Sayanagi M Sawa H Sakaguchi Y Oshima, et al. 2008 One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients Ophthalmology 115 141 146 17582498 10.1016/j.ophtha.2007.02.031 (Pubitemid 350309415)
4. RM Silva J Figueira ML Cachulo L Duarte JR Faria de Abreu JG Cunha-Vaz 2005 Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin Graefes Arch Clin Exp Ophthalmol 243 973 979 15864616 10.1007/s00417-005-1139-4 1:CAS:528:DC%2BD2MXhtFart7fN (Pubitemid 41631036)
5. Y Kurashige A Otani M Sasahara Y Yodoi H Tamura A Tsujikawa, et al. 2008 Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 146 513 519 18614133 10.1016/j.ajo.2008.05.025
6. K Yamashiro A Tsujikawa A Nishida M Mandai Y Kurimoto 2008 Recurrence of polypoidal choroidal vasculopathy after photodynamic therapy Jpn J Ophthalmol 52 457 462 19089566 10.1007/s10384-008-0582-2
7. DM Brown M Michels PK Kaiser JS Heier JP Sy T Ianchulev 2009 Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study Ophthalmology 116 57 65 19118696 10.1016/j.ophtha.2008.10.018
8. F Gomi M Sawa H Sakaguchi M Tsujikawa Y Oshima M Kamei, et al. 2008 Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy Br J Ophthalmol 92 70 73 17567661 10.1136/bjo.2007.122283 1:STN:280: DC%2BD2sjlvFyltQ%3D%3D
9. H Tamura A Tsujikawa A Otani N Gotoh M Sasahara T Kameda, et al. 2007 Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiography Br J Ophthalmol 91 1152 1159 17314148 10.1136/bjo.2006.112318 (Pubitemid 47344888)
10. A Otani M Sasahara Y Yodoi H Aikawa H Tamura A Tsujikawa, et al. 2007 Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 144 7 14 17467649 10.1016/j.ajo.2007.03. 014 1:CAS:528:DC%2BD2sXntF2kurY%3D (Pubitemid 46963181)
11. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group 1999 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report Arch Ophthalmol 117 1329 1345
12. E Akaza R Mori M Yuzawa 2008 Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy Retina 28 717 722 18463515 10.1097/IAE.0b013e31816577cb (Pubitemid 351655124)
13. T Wakabayashi F Gomi M Sawa M Tsujikawa Y Tano 2008 Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy Br J Ophthalmol 92 936 940 18577645 10.1136/bjo.2007.132357 1:STN:280: DC%2BD1cvgvVCgtQ%3D%3D (Pubitemid 351969674)
14. Verteporfin in photodynamic therapy study group 2001 Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2 Am J Ophthalmol 131 541 560 10.1016/S0002-9394(01)00967-9 (Pubitemid 32427660)
15. RF Spaide LA Yannuzzi JS Slakter J Sorenson DA Orlach 1995 Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy Retina 15 100 110 7542796 10.1097/00006982-199515020-00003 1:STN:280:DyaK2MzltVCmsw%3D%3D
16. LA Yannuzzi DW Wong BS Sforzolini M Goldbaum KC Tang RF Spaide, et al. 1999 Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration Arch Ophthalmol 117 1503 1510 10565519 1:STN:280: DC%2BD3c%2FivFanuw%3D%3D (Pubitemid 29536478)
17. M Uyama M Wada Y Nagai T Matsubara H Matsunaga I Fukushima, et al. 2002 Polypoidal choroidal vasculopathy: natural history Am J Ophthalmol 133 639 648 11992861 10.1016/S0002-9394(02)01404-6 (Pubitemid 34462012)
18. O Tatar E Kaiserling A Adam F Gelisken K Shinoda M Völker, et al. 2006 Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes Arch Ophthalmol 124 815 823 16769835 10.1001/archopht.124.6.815 1:CAS:528:DC%2BD28XmtlWnur0%3D (Pubitemid 43877675)
19. O Tatar A Adam K Shinoda P Stalmans C Eckardt M Lüke, et al. 2006 Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy Am J Ophthalmol 142 95 104 16815256 10.1016/j.ajo.2006.01.085 1:CAS:528:DC%2BD28Xms1Gkurw%3D (Pubitemid 43949615)
20. T Busch 2009 Approaches toward combining photodynamic therapy with pharmaceuticals that alter vascular microenvironment Retina 29 S36 S38 19553798 10.1097/IAE.0b013e3181ad25e8
21. M Saito T Iida D Nagayama 2008 Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment Br J Ophthalmol 92 1642 1647 18782798 10.1136/bjo.2007.137075 1:STN:280: DC%2BD1cjlsF2ntw%3D%3D
22. R Mori M Yuzawa Z Lee M Haruyama E Akaza 2010 Factors influencing visual outcome of polypoidal choroidal vasculopathy one year after photodynamic therapy Graefes Arch Clin Exp Ophthalmol 248 1233 1239 20352440 10.1007/s00417-010- 1365-2
23. AN Antoszyk L Tuomi CY Chung A Singh 2008 Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results Am J Ophthalmol 145 862 874 18321465 10.1016/j.ajo.2007.12.029 1:CAS:528:DC%2BD1cXlsFChsr8%3D
24. T Sato S Kishi H Matsumoto R Mukai 2010 Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy Am J Ophthalmol 149 947 954 20346441 10.1016/j.ajo.2009.12.038 1:CAS:528:DC%2BC3cXmslSmt7c%3D